On-Demand Loco-Regional Treatment for Intrahepatic Lesions Improves Treatment Outcomes in Atezolizumab Plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma.

Cancers (Basel) · 2026 · PMC13025880 · PMID 41899622

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significancep = 0.087so close (0.05 < p ≤ 0.1)

showed a trendno p-value reported

OS also showed a trend toward improvement in the IHLRT+ group, although this did not reach statistical significance (31.8 vs. 24.2 months; 95% CI: 21.0–42.7 vs. 10.7–37.7; p = 0.087) ( Figure 1 B).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.